Vachon Virginia K, Conn Graeme L
Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA; Microbiology and Molecular Genetics (MMG) Program, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Virus Res. 2016 Jan 2;212:39-52. doi: 10.1016/j.virusres.2015.06.018. Epub 2015 Jun 25.
Adenovirus (AdV) 'virus-associated' RNAs (VA RNAs) are exceptionally abundant (up to 10(8)copies/cell), heterogeneous, non-coding RNA transcripts (∼ 150-200 nucleotides). The predominant species, VA RNAI, is best recognized for its essential function in relieving the cellular anti-viral blockade of protein synthesis through inhibition of the double-stranded RNA-activated protein kinase (PKR). More recent evidence has revealed that VA RNAs also interfere with several other host cell processes, in part by virtue of the high level to which they accumulate. Following transcription by cellular RNA polymerase III, VA RNAs saturate the nuclear export protein Exportin 5 (Exp5) and the cellular endoribonculease Dicer, interfering with pre-micro (mi)RNA export and miRNA biogenesis, respectively. Dicer-processed VA RNA fragments are incorporated into the RNA-induced silencing complex (RISC) as 'mivaRNAs', where they may specifically target cellular genes. VA RNAI also interacts with other innate immune proteins, including OAS1. While intact VA RNAI has the paradoxical effect of activating OAS1, a non-natural VA RNAI construct lacking the entire Terminal Stem has been reported to be a pseudoinhibitor of OAS1. Here, we show that a VA RNAI construct corresponding to an authentic product of Dicer processing similarly fails to activate OAS1 but also retains only a modest level of inhibitory activity against PKR in contrast to the non-natural deletion construct. These findings underscore the complexity of the arms race between virus and host, and highlight the need for further exploration of the impact of VA RNAI interactions with host defenses on the outcome of AdV infection beyond that of well-established PKR inhibition. Additional contributions of VA RNAI heterogeneity resulting from variations in transcription initiation and termination to each of these functions remain open questions that are discussed here.
腺病毒(AdV)的“病毒相关”RNA(VA RNA)含量异常丰富(高达10⁸拷贝/细胞),是异质性的非编码RNA转录本(约150 - 200个核苷酸)。主要种类VA RNAI最为人所知的是其通过抑制双链RNA激活蛋白激酶(PKR)来解除细胞对蛋白质合成的抗病毒阻断的基本功能。最近的证据表明,VA RNA还会干扰其他几种宿主细胞过程,部分原因是它们积累的水平很高。在由细胞RNA聚合酶III转录后,VA RNA会使核输出蛋白Exportin 5(Exp5)和细胞内核糖核酸酶Dicer饱和,分别干扰前体微小(mi)RNA的输出和miRNA的生物合成。经Dicer处理的VA RNA片段作为“mivaRNAs”被整合到RNA诱导沉默复合体(RISC)中,在那里它们可能特异性靶向细胞基因。VA RNAI还与其他先天免疫蛋白相互作用,包括OAS1。虽然完整的VA RNAI具有激活OAS1的矛盾作用,但据报道,一种缺乏整个末端茎的非天然VA RNAI构建体是OAS1的假抑制剂。在这里,我们表明,与Dicer加工的真实产物相对应的VA RNAI构建体同样无法激活OAS1,但与非天然缺失构建体相比,对PKR的抑制活性也仅处于中等水平。这些发现强调了病毒与宿主之间军备竞赛的复杂性,并突出了除了已确定的PKR抑制作用之外,进一步探索VA RNAI与宿主防御相互作用对AdV感染结果的影响的必要性。转录起始和终止变化导致的VA RNAI异质性对这些功能的额外贡献仍然是悬而未决的问题,本文将对此进行讨论。